Hidden Bibliographic Details
| Varying Form of Title: | Financing vaccines in the twenty-first century
|
|---|
| Other authors / contributors: | Institute of Medicine (U.S.). Committee on the Evaluation of Vaccine Purchase Financing in the United States.
|
|---|
| ISBN: | 0309526191
9780309526197
1280116099
9781280116094
9786610116096
6610116091
0309089794
9780309089791
|
|---|
| Digital file characteristics: | data file
|
|---|
| Notes: | Includes bibliographical references (pages 211-220).
Restrictions unspecified
Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2011.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
digitized 2011 HathiTrust Digital Library committed to preserve
Print version record.
|
|---|
| Summary: | The national immunization system has achieved high levels of immunization, particularly for children. However, this system faces difficult challenges for the future. Significant disparities remain in assuring access to recommended vaccines across geographic and demographic populations. These disparities result, in part, from fragmented public-private financing in which a large number of children and adults face limited access to immunization services. Access for adults lags well behind that of children, and rates of immunizations for those who are especially vulnerable because of chronic health conditions such as diabetes or heart and lung disease, remain low. "Financing Vaccines in the 21st Century: Assuring Access and Availability addresses these challenges by proposing new strategies for assuring access to vaccines and sustaining the supply of current and future vaccines. The book recommends changes to the Advisory Committee on Immunization Practices (AC1P)--the entity that currently recommends vaccines--and calls for a series of public meetings, a post-implementation evaluation study, and development of a research agenda to facilitate implementation of the plan.
|
|---|
| Other form: | Financing vaccines in the 21st century
|
|---|
